The global empty IV bags market is expected to witness substantial growth over the coming years as healthcare systems continue to expand and demand for advanced infusion delivery solutions increases. According to recent market analysis, the global empty IV bags market was valued at USD 5.85 billion in 2025 and is projected to grow from USD 6.35 billion in 2026 to USD 12.19 billion by 2034, registering a compound annual growth rate (CAGR) of 8.5% during the forecast period.

Empty IV bags are essential medical packaging products used for the storage, preparation, transportation, and administration of intravenous fluids, medications, nutrition solutions, and blood products. These bags play a critical role in modern healthcare settings, including hospitals, clinics, ambulatory surgical centers, blood banks, and home healthcare services. Growing emphasis on patient safety, medication compatibility, and environmentally sustainable materials is driving innovation and adoption across the market.

Market Overview

The empty IV bags market is evolving as healthcare providers seek safer, more efficient, and environmentally responsible infusion delivery systems. The increasing burden of chronic diseases, rising rates of malnutrition, expanding geriatric populations, and growing healthcare expenditures are contributing to greater demand for intravenous therapies globally.

Manufacturers are focusing on developing advanced IV bag solutions with improved drug compatibility, enhanced durability, reduced contamination risks, and safer materials. The market is also witnessing a gradual shift toward non-PVC and DEHP-free alternatives as healthcare organizations seek to address concerns related to patient safety and environmental sustainability.

Growing investments in healthcare infrastructure, particularly across emerging economies, continue to support demand for IV administration products and related medical packaging solutions.

Growth Drivers

One of the primary factors driving market growth is the increasing support from government agencies and healthcare regulators. Several countries have introduced initiatives aimed at reducing the use of potentially harmful plasticizers, including phthalates, in medical devices and packaging materials.

Regulatory authorities in Europe and North America are encouraging healthcare providers and manufacturers to adopt safer alternatives to traditional PVC-based products. These initiatives are accelerating innovation in IV bag materials and supporting the transition toward advanced non-PVC solutions.

Favorable reimbursement policies are also contributing to market expansion. Healthcare systems in many countries provide coverage for medical procedures and therapies that require intravenous administration, supporting consistent demand for IV bags and related infusion products.

Another significant growth factor is the increasing prevalence of malnutrition and chronic health conditions. Intravenous nutrition and fluid therapy remain essential components of patient care for individuals suffering from severe nutritional deficiencies, cancer, gastrointestinal disorders, cardiovascular diseases, and other chronic illnesses.

As global populations continue to age, the demand for infusion therapies and intravenous nutritional support is expected to increase, creating additional opportunities for market growth.

Industry Trends

A key trend shaping the market is the transition toward non-PVC and DEHP-free IV bags. Healthcare providers are increasingly adopting alternative materials due to concerns regarding chemical leaching, drug compatibility, and environmental impact associated with traditional PVC-based products.

Manufacturers are investing heavily in research and development to create safer materials that offer improved transparency, durability, flexibility, and compatibility with a wide range of pharmaceutical formulations.

Another notable trend is the growing use of advanced multi-chamber IV bag systems. These solutions allow unstable medications to be stored separately and mixed immediately before administration, improving drug stability, reducing preparation errors, and enhancing patient safety.

Technological advancements are also enabling the development of specialized IV bags designed for complex therapies, personalized medicine applications, blood component storage, and parenteral nutrition.

Market Challenges

Despite positive growth prospects, the market faces several challenges. One of the most significant barriers is the higher cost associated with non-PVC IV bags compared to traditional PVC alternatives.

Although non-PVC materials offer advantages related to patient safety and environmental performance, their manufacturing costs remain relatively high. This price difference can create budgetary challenges for healthcare facilities, particularly in cost-sensitive regions.

Additionally, intense competition among suppliers often results in pricing pressure and reduced profit margins. Bulk purchasing agreements and hospital procurement contracts may further limit revenue growth for manufacturers despite increasing demand.

Supply chain disruptions, fluctuating raw material costs, and regulatory compliance requirements also present ongoing challenges for market participants.

Growth Opportunities

Advancements in IV bag manufacturing technology are creating significant opportunities for industry growth. Manufacturers are developing innovative materials and designs that improve drug compatibility, extend product shelf life, and reduce contamination risks.

The increasing demand for personalized healthcare solutions and specialized infusion therapies is expected to drive adoption of advanced IV bag systems. Innovations such as dual-chamber and multi-chamber bags are enabling healthcare providers to deliver complex medications more efficiently while reducing waste and preparation time.

Emerging markets across Asia-Pacific, Latin America, and the Middle East & Africa also present substantial growth opportunities. Expanding healthcare infrastructure, rising healthcare expenditures, and growing awareness of advanced medical technologies are expected to support increased demand for IV administration products throughout these regions.

Regional Insights

North America remains the dominant regional market for empty IV bags and is expected to maintain its leadership position during the forecast period. The region benefits from advanced healthcare infrastructure, strong distribution networks, favorable reimbursement systems, and a well-established regulatory framework.

The United States continues to represent a major contributor to regional demand due to the high prevalence of chronic diseases, increasing hospital admissions, and ongoing efforts by regulatory agencies to improve patient safety and promote the adoption of safer medical materials.

Europe is projected to be the fastest-growing regional market. Increasing cancer incidence, growing healthcare investments, and regulatory initiatives focused on reducing the use of PVC and phthalates in medical devices are supporting market expansion across the region.

Asia-Pacific is also expected to experience significant growth driven by expanding healthcare access, rising healthcare expenditures, aging populations, and increasing demand for cost-effective medical solutions. Countries such as China, India, Japan, and South Korea are investing heavily in healthcare modernization and infrastructure development.

Latin America and the Middle East & Africa are emerging as attractive growth markets due to improving healthcare systems, growing medical tourism, and increasing adoption of advanced infusion technologies.

Segment Analysis

By product type, the PVC segment currently accounts for the largest share of the market due to its affordability, flexibility, and widespread use in packaging intravenous fluids, nutritional solutions, antibiotics, and other pharmaceutical products.

However, the non-PVC segment is expected to gain increasing attention during the forecast period as healthcare providers seek safer and more environmentally sustainable alternatives.

Based on material, ethylene-vinyl acetate (EVA) represents the leading segment. EVA offers superior transparency, durability, chemical resistance, and safety characteristics, making it highly suitable for storing blood components, frozen mixtures, and sensitive pharmaceutical formulations.

The growing demand for blood collection and storage products, combined with increasing adoption of DEHP-free solutions, is expected to further strengthen the position of EVA-based IV bags in the global market.

Competitive Landscape

The global empty IV bags market is characterized by the presence of established medical device manufacturers and specialized packaging providers. Companies are focusing on product innovation, strategic partnerships, acquisitions, and manufacturing expansion to strengthen their market positions.

Key companies operating in the market include Baxter, Braun Medical Inc., ICU Medical Inc., Wipak, RENOLIT SE, TECHNOFLEX, Sippex IV Bags, JW Life Science Corp, Fresenius Kabi AG, POLYCINE GmbH, BAUSCH Advanced Technology Group, and BD.

Recent developments within the industry have focused on advanced chamber bag technologies, safer material formulations, and strategic acquisitions aimed at expanding product portfolios and global market reach.

About the Market Study

This study provides a comprehensive assessment of the global empty IV bags market across product types, material categories, regional markets, and key industry participants. The report evaluates growth drivers, technological advancements, regulatory developments, market challenges, competitive strategies, and future opportunities shaping the industry from 2026 through 2034.

The analysis covers major geographic regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, providing detailed insights into evolving healthcare trends and market dynamics.

Click to Read the Complete Insights & Report:https://straitsresearch.com/report/empty-iv-bags-market

About Straits Research

Straits Research is a global market research and consulting company that delivers comprehensive industry intelligence, market forecasts, competitive analysis, and strategic business insights. Through rigorous research methodologies and data-driven analysis, Straits Research helps organizations identify growth opportunities, evaluate emerging trends, and make informed business decisions across a wide range of industries and markets worldwide.